Expression of the p73 protein in rectal cancers with or without preoperative radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 65, Issue 4, 2006, Pages 1143-1148

  Pfeifer, Daniella ^a   Gao, Jingfang ^a   Adell, Gunnar ^a   Sun, Xiao Feng ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Immunohistochemistry; Local recurrence; p73; Radiotherapy; Rectal cancer

Indexed keywords

CELLS; HISTOLOGY; IMMUNOLOGY; PROTEINS; TUMORS;

IMMUNOHISTOCHEMISTRY; LOCAL RECURRENCE; P73; RECTAL CANCER;

RADIOTHERAPY;

CYCLOOXYGENASE 2; CYTOPLASM PROTEIN; NUCLEAR PROTEIN; PROTEIN P73;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECTUM CANCER; RECTUM MUCOSA; TUMOR BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; CYCLOOXYGENASE 2; DNA-BINDING PROTEINS; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; INTESTINAL MUCOSA; LYMPHATIC METASTASIS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NUCLEAR PROTEINS; PROPORTIONAL HAZARDS MODELS; RECTAL NEOPLASMS; TUMOR SUPPRESSOR PROTEINS;

EID: 33745212040     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.02.028     Document Type: Article

References (27)

1. Dahlberg M., Pahlman L., Bergstrom R., et al. Improved survival in patients with rectal cancer. A population-based register study. Br J Surg 85 (1998) 515-520
2. Holm T., Rutqvist L.E., Johansson H., et al. Postoperative mortality in rectal cancer treated with or without preoperative radiotherapy. Causes and risk factors. Br J Surg 83 (1996) 964-968
3. Glimelius B., Gronberg H., Jarhult J., et al. A systematic overview of radiation therapy effects in rectal cancer. Acta Oncol 42 (2003) 476-492
4. Myerson R.J., Michalski J.M., King M.L., et al. Adjuvant radiation therapy for rectal carcinoma. Predictors of outcome. Int J Radiat Oncol Biol Phys 32 (1995) 41-50
5. Stift A., Prager G., Selzer E., et al. The early response of p53-dependent proteins during radiotherapy in human rectal carcinoma and in adjacent normal tissue. Int J Oncol 23 (2003) 1269-1275
6. Adell G., Sun X.F., Stal O., et al. p53 status. An indicator for the effect of preoperative radiotherapy of rectal cancer. Radiother Oncol 51 (1999) 169-174
7. Bénard J., Douc-Rasy S., and Ahomadegbe J.C. TP53 family members and human cancers. Hum Mutat 21 (2003) 182-191
8. Liu S.S., Leung R.C., Chan K.Y., et al. p73 expression is associated with the cellular radiosensitivity in cervical cancer after radiotherapy. Clin Cancer Res 15 (2004) 3309-3316
9. Yamamoto T., Oda K., Kubota T., et al. Expression of p73 gene, cell proliferation and apoptosis in breast cancer. Immunohistochemical and clinicopathological study. Oncol Rep 9 (2002) 729-735
10. Moll U.M., Erster S., and Zaika A. p53, p63 and p73-solos, alliances and feuds among family members. Biochim Biophys Acta 28 (2001) 47-59
11. Yang A., Walker N., Bronson R., et al. p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature 404 (2000) 99-103
12. Sun X.F. p73 overexpression is a prognostic factor in patients with colorectal adenocarcinoma. Clin Cancer Res 8 (2002) 165-170
13. Merlo P., Fulco M., Costanzo A., et al. A role of p73 in mitotic exit. J Biol Chem 280 (2005) 30354-30360
14. Swedish Rectal Cancer Trial. Initial report from a Swedish multicentre study examining the role of preoperative irradiation in the treatment of patients with resectable rectal carcinoma. Swedish Rectal Cancer Trial. Br J Surg 80 (1993) 1333-1336
15. Adell G.C., Zhang H., Evertsson S., et al. Apoptosis in rectal carcinoma. Prognosis and recurrence after preoperative radiotherapy. Cancer 91 (2001) 1870-1875
16. Adell G., Zhang H., Jansson A., et al. Decreased tumor cell proliferation as an indicator of the effect of preoperative radiotherapy of rectal cancer. Int J Radiat Oncol Biol Phys 50 (2001) 659-663
17. Pachkoria K., Zhang H., Adell G., et al. Cox-2 expression in rectal cancer patients with or without preoperative radiotherapy. Int J Radiat Oncol Biol Phys 63 (2005) 739-744
18. Knutsen A., Adell G., and Sun X.F. Survivin expression is an independent prognostic factor in rectal cancer patients with and without preoperative radiotherapy. Int J Radiat Oncol Biol Phys 60 (2004) 149-155
19. Rosen E.M., Fan S., Rockwell S., et al. The molecular and cellular basis of radiosensitivity. Implications for understanding how normal tissues and tumors respond to therapeutic radiation. Cancer Invest 17 (1999) 56-72
20. Vayssade M., Haddada H., Faridoni-Laurens L., et al. P73 functionally replaces p53 in Adriamycin-treated, p53-deficient breast cancer cells. Int J Cancer 10 (2005) 860-869
21. Ben-Yehoyada M., Ben-Dor I., and Shaul Y. c-Abl tyrosine kinase selectively regulates p73 nuclear matrix association. J Biol Chem 5 (2003) 34475-34482
22. Singh A., Sharma H., Salhan S., et al. Evaluation of expression of apoptosis-related proteins and their correlation with HPV, telomerase activity, and apoptotic index in cervical cancer. Pathobiology 71 (2004) 314-322
23. Swamy M.V., Herzog C.R., and Rao C.V. Inhibition of COX-2 in colon cancer cell lines by celecoxib increases the nuclear localization of active p53. Cancer Res 1 (2003) 5239-5242
24. Maisse C., Munarriz E., Barcaroli D., et al. DNA damage induces the rapid and selective degradation of the ΔNp73 isoform, allowing apoptosis to occur. Cell Death Differ 11 (2004) 685-687
25. Munarriz E., Bano D., Sayan A.E., Rossi M., Melino G., and Nicotera P. Calpain cleavage regulates the protein stability of p73. Biochem Biophys Res Commun 5 (2005) 954-960
26. Rossi M., De Laurenzi V., Munarriz E., et al. The ubiquitin-protein ligase Itch regulates p73 stability. EMBO J 23 (2005) 836-848
27. Ramadan S., Terrinoni A., Catani M.V., et al. p73 induces apoptosis by different mechanisms. Biochem Biophys Res Commun 10 (2005) 713-717